Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions (RAIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03805841
Recruitment Status : Recruiting
First Posted : January 16, 2019
Last Update Posted : August 12, 2020
Sponsor:
Information provided by (Responsible Party):
Rain Therapeutics Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 15, 2021
Estimated Study Completion Date : March 15, 2021